Allianz Asset Management Gmb H Regenxbio Inc. Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Regenxbio Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 39,300 shares of RGNX stock, worth $299,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,300

Previous 92,600 57.56%

Holding current value

$299,466

Previous $1.08 Million 61.96%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.49 - $14.39 $559,117 - $766,987	-53,300 Reduced 57.56%	39,300 $412,000
Q2 2024 Aug 13, 2024	BUY	$11.51 - $21.53 $1.07 Million - $1.99 Million	92,600 New	92,600 $1.08 Million
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $435,064 - $681,052	-15,678 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $488,566 - $1.23 Million	-22,724 Reduced 59.17%	15,678 $508,000
Q4 2019 Feb 13, 2020	BUY	$34.54 - $44.87 $789,100 - $1.03 Million	22,846 Added 146.86%	38,402 $1.57 Million
Q3 2019 Nov 13, 2019	SELL	$31.84 - $50.88 $2.71 Million - $4.34 Million	-85,201 Reduced 84.56%	15,556 $554,000
Q2 2019 Aug 08, 2019	BUY	$42.0 - $59.29 $1.43 Million - $2.01 Million	33,944 Added 50.8%	100,757 $5.18 Million
Q1 2019 May 13, 2019	BUY	$40.82 - $62.45 $1.71 Million - $2.62 Million	41,987 Added 169.13%	66,813 $3.83 Million
Q4 2018 Feb 14, 2019	SELL	$39.11 - $75.15 $2.58 Million - $4.95 Million	-65,899 Reduced 72.64%	24,826 $1.04 Million
Q3 2018 Nov 13, 2018	SELL	$65.0 - $82.15 $1.22 Million - $1.54 Million	-18,780 Reduced 17.15%	90,725 $6.85 Million
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $1.83 Million - $5 Million	67,296 Added 159.44%	109,505 $7.86 Million
Q1 2018 May 14, 2018	BUY	$24.05 - $37.5 $1.02 Million - $1.58 Million	42,209 New	42,209 $1.26 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Regenxbio Inc. Transaction History